ZA200510318B - Tablets containing enrofloxacin and flavouring agents and/or flavours - Google Patents

Tablets containing enrofloxacin and flavouring agents and/or flavours Download PDF

Info

Publication number: ZA200510318B
Authority: ZA; South Africa
Prior art keywords: weight; tablets; enrofloxacin; acid; animals
Prior art date: 2003-06-26

Application number

ZA200510318A

Other languages

English (en)

Inventor

Kanikanti Venkata-Rangarao

Bongaerts Sabine

Original Assignee

Bayer Healthcare Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-06-26

Filing date

2005-12-20

Publication date

2007-04-25

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33520986&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA200510318(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-20 Application filed by Bayer Healthcare Ag filed Critical Bayer Healthcare Ag

2007-04-25 Publication of ZA200510318B publication Critical patent/ZA200510318B/en

Links

239000000796 flavoring agent Substances 0.000 title claims description 20
235000019634 flavors Nutrition 0.000 title claims description 16
SPFYMRJSYKOXGV-UHFFFAOYSA-N Baytril Chemical compound C1CN(CC)CCN1C(C(=C1)F)=CC2=C1C(=O)C(C(O)=O)=CN2C1CC1 SPFYMRJSYKOXGV-UHFFFAOYSA-N 0.000 title claims description 14
229960000740 enrofloxacin Drugs 0.000 title claims description 13
235000013355 food flavoring agent Nutrition 0.000 title description 2
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 9
239000002671 adjuvant Substances 0.000 claims description 9
235000013372 meat Nutrition 0.000 claims description 9
239000000203 mixture Substances 0.000 claims description 8
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 7
239000008101 lactose Substances 0.000 claims description 7
229920000168 Microcrystalline cellulose Polymers 0.000 claims description 6
235000019813 microcrystalline cellulose Nutrition 0.000 claims description 6
239000008108 microcrystalline cellulose Substances 0.000 claims description 6
229940016286 microcrystalline cellulose Drugs 0.000 claims description 6
238000001035 drying Methods 0.000 claims description 4
239000007864 aqueous solution Substances 0.000 claims description 3
238000000034 method Methods 0.000 claims description 3
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
241001465754 Metazoa Species 0.000 description 23
241000283690 Bos taurus Species 0.000 description 10
241000282887 Suidae Species 0.000 description 10
229920002472 Starch Polymers 0.000 description 8
235000019698 starch Nutrition 0.000 description 8
239000000126 substance Substances 0.000 description 8
241001494479 Pecora Species 0.000 description 7
239000000546 pharmaceutical excipient Substances 0.000 description 7
239000008107 starch Substances 0.000 description 7
241000282472 Canis lupus familiaris Species 0.000 description 6
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
150000003839 salts Chemical class 0.000 description 6
229960001375 lactose Drugs 0.000 description 5
229920000036 polyvinylpyrrolidone Polymers 0.000 description 5
235000013855 polyvinylpyrrolidone Nutrition 0.000 description 5
241000283086 Equidae Species 0.000 description 4
238000010171 animal model Methods 0.000 description 4
150000004677 hydrates Chemical class 0.000 description 4
208000015181 infectious disease Diseases 0.000 description 4
239000001267 polyvinylpyrrolidone Substances 0.000 description 4
QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical class CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
241000282326 Felis catus Species 0.000 description 3
206010035664 Pneumonia Diseases 0.000 description 3
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
235000019359 magnesium stearate Nutrition 0.000 description 3
208000004396 mastitis Diseases 0.000 description 3
235000012239 silicon dioxide Nutrition 0.000 description 3
208000035143 Bacterial infection Diseases 0.000 description 2
VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
241000589876 Campylobacter Species 0.000 description 2
241000283707 Capra Species 0.000 description 2
229920002261 Corn starch Polymers 0.000 description 2
RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical class OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical class Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
206010024238 Leptospirosis Diseases 0.000 description 2
235000019759 Maize starch Nutrition 0.000 description 2
206010037151 Psittacosis Diseases 0.000 description 2
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
238000005299 abrasion Methods 0.000 description 2
-1 alkali metal salts Chemical class 0.000 description 2
150000001447 alkali salts Chemical class 0.000 description 2
PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
235000015278 beef Nutrition 0.000 description 2
239000011230 binding agent Substances 0.000 description 2
238000009395 breeding Methods 0.000 description 2
230000001488 breeding effect Effects 0.000 description 2
229940075614 colloidal silicon dioxide Drugs 0.000 description 2
239000003814 drug Substances 0.000 description 2
239000004615 ingredient Substances 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical class CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000000314 lubricant Substances 0.000 description 2
235000012054 meals Nutrition 0.000 description 2
201000000901 ornithosis Diseases 0.000 description 2
235000019629 palatability Nutrition 0.000 description 2
244000144977 poultry Species 0.000 description 2
239000000843 powder Substances 0.000 description 2
239000000377 silicon dioxide Substances 0.000 description 2
WSVLPVUVIUVCRA-KPKNDVKVSA-N Alpha-lactose monohydrate Chemical compound O.O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O WSVLPVUVIUVCRA-KPKNDVKVSA-N 0.000 description 1
201000008283 Atrophic Rhinitis Diseases 0.000 description 1
241000193738 Bacillus anthracis Species 0.000 description 1
208000003508 Botulism Diseases 0.000 description 1
206010006500 Brucellosis Diseases 0.000 description 1
241000030939 Bubalus bubalis Species 0.000 description 1
206010069747 Burkholderia mallei infection Diseases 0.000 description 1
241000282832 Camelidae Species 0.000 description 1
241000700198 Cavia Species 0.000 description 1
241000700112 Chinchilla Species 0.000 description 1
241000207205 Citrus greening disease-associated bacterium Species 0.000 description 1
206010010741 Conjunctivitis Diseases 0.000 description 1
229920002785 Croscarmellose sodium Polymers 0.000 description 1
AEMOLEFTQBMNLQ-YMDCURPLSA-N D-galactopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-YMDCURPLSA-N 0.000 description 1
RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
241000283014 Dama Species 0.000 description 1
FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
208000004232 Enteritis Diseases 0.000 description 1
241000283074 Equus asinus Species 0.000 description 1
201000000297 Erysipelas Diseases 0.000 description 1
206010061126 Escherichia infection Diseases 0.000 description 1
206010017564 Fusobacterium infections Diseases 0.000 description 1
IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
239000001828 Gelatine Substances 0.000 description 1
201000003641 Glanders Diseases 0.000 description 1
WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical class NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 1
206010061259 Klebsiella infection Diseases 0.000 description 1
208000024233 Klebsiella infectious disease Diseases 0.000 description 1
CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
206010024641 Listeriosis Diseases 0.000 description 1
241000124008 Mammalia Species 0.000 description 1
241000699673 Mesocricetus auratus Species 0.000 description 1
AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 1
241000699670 Mus sp. Species 0.000 description 1
241000204031 Mycoplasma Species 0.000 description 1
206010028846 Necrobacillosis Diseases 0.000 description 1
241000772415 Neovison vison Species 0.000 description 1
206010029443 Nocardia Infections Diseases 0.000 description 1
206010029444 Nocardiosis Diseases 0.000 description 1
241000283973 Oryctolagus cuniculus Species 0.000 description 1
229910019142 PO4 Inorganic materials 0.000 description 1
208000026681 Paratuberculosis Diseases 0.000 description 1
206010034107 Pasteurella infections Diseases 0.000 description 1
208000035109 Pneumococcal Infections Diseases 0.000 description 1
206010035673 Pneumonia chlamydial Diseases 0.000 description 1
241000282330 Procyon lotor Species 0.000 description 1
208000006311 Pyoderma Diseases 0.000 description 1
206010037688 Q fever Diseases 0.000 description 1
241000283011 Rangifer Species 0.000 description 1
241000700159 Rattus Species 0.000 description 1
206010039088 Rhinitis atrophic Diseases 0.000 description 1
241000282849 Ruminantia Species 0.000 description 1
206010039438 Salmonella Infections Diseases 0.000 description 1
206010040047 Sepsis Diseases 0.000 description 1
235000021355 Stearic acid Nutrition 0.000 description 1
206010061372 Streptococcal infection Diseases 0.000 description 1
KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Chemical class OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical class OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 1
241000282898 Sus scrofa Species 0.000 description 1
FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
206010043376 Tetanus Diseases 0.000 description 1
241000186064 Trueperella pyogenes Species 0.000 description 1
206010046793 Uterine inflammation Diseases 0.000 description 1
208000025087 Yersinia pseudotuberculosis infectious disease Diseases 0.000 description 1
206010000210 abortion Diseases 0.000 description 1
231100000176 abortion Toxicity 0.000 description 1
239000002253 acid Substances 0.000 description 1
230000002378 acidificating effect Effects 0.000 description 1
229910052783 alkali metal Inorganic materials 0.000 description 1
229910052784 alkaline earth metal Inorganic materials 0.000 description 1
229960004977 anhydrous lactose Drugs 0.000 description 1
238000003975 animal breeding Methods 0.000 description 1
235000019568 aromas Nutrition 0.000 description 1
235000003704 aspartic acid Nutrition 0.000 description 1
235000012216 bentonite Nutrition 0.000 description 1
OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
230000003115 biocidal effect Effects 0.000 description 1
KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical class O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
229910000019 calcium carbonate Inorganic materials 0.000 description 1
159000000007 calcium salts Chemical class 0.000 description 1
244000309466 calf Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical class OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
150000004649 carbonic acid derivatives Chemical class 0.000 description 1
239000001913 cellulose Substances 0.000 description 1
229920002678 cellulose Polymers 0.000 description 1
235000010980 cellulose Nutrition 0.000 description 1
229920003086 cellulose ether Polymers 0.000 description 1
235000015165 citric acid Nutrition 0.000 description 1
239000001767 crosslinked sodium carboxy methyl cellulose Substances 0.000 description 1
235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
201000010099 disease Diseases 0.000 description 1
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
239000002706 dry binder Substances 0.000 description 1
208000001848 dysentery Diseases 0.000 description 1
201000002491 encephalomyelitis Diseases 0.000 description 1
208000020612 escherichia coli infection Diseases 0.000 description 1
235000013312 flour Nutrition 0.000 description 1
229920000159 gelatin Polymers 0.000 description 1
235000019322 gelatine Nutrition 0.000 description 1
239000000174 gluconic acid Substances 0.000 description 1
235000012208 gluconic acid Nutrition 0.000 description 1
235000013922 glutamic acid Nutrition 0.000 description 1
239000004220 glutamic acid Substances 0.000 description 1
230000002458 infectious effect Effects 0.000 description 1
150000002500 ions Chemical class 0.000 description 1
239000004310 lactic acid Chemical class 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
229960001021 lactose monohydrate Drugs 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
159000000003 magnesium salts Chemical class 0.000 description 1
235000013336 milk Nutrition 0.000 description 1
239000008267 milk Substances 0.000 description 1
210000004080 milk Anatomy 0.000 description 1
QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
206010033072 otitis externa Diseases 0.000 description 1
WLJNZVDCPSBLRP-UHFFFAOYSA-N pamoic acid Chemical compound C1=CC=C2C(CC=3C4=CC=CC=C4C=C(C=3O)C(=O)O)=C(O)C(C(O)=O)=CC2=C1 WLJNZVDCPSBLRP-UHFFFAOYSA-N 0.000 description 1
229940124531 pharmaceutical excipient Drugs 0.000 description 1
235000021317 phosphate Nutrition 0.000 description 1
150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
201000006509 pleuropneumonia Diseases 0.000 description 1
159000000001 potassium salts Chemical class 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
238000011321 prophylaxis Methods 0.000 description 1
206010039447 salmonellosis Diseases 0.000 description 1
125000005624 silicic acid group Chemical class 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
159000000000 sodium salts Chemical class 0.000 description 1
239000007787 solid Substances 0.000 description 1
238000001228 spectrum Methods 0.000 description 1
239000008117 stearic acid Substances 0.000 description 1
235000000346 sugar Nutrition 0.000 description 1
150000008163 sugars Chemical class 0.000 description 1
239000001117 sulphuric acid Chemical class 0.000 description 1
235000011149 sulphuric acid Nutrition 0.000 description 1
208000011580 syndromic disease Diseases 0.000 description 1
230000009897 systematic effect Effects 0.000 description 1
239000000454 talc Substances 0.000 description 1
235000012222 talc Nutrition 0.000 description 1
229910052623 talc Inorganic materials 0.000 description 1
239000011975 tartaric acid Substances 0.000 description 1
235000002906 tartaric acid Nutrition 0.000 description 1
JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
238000011282 treatment Methods 0.000 description 1
201000008827 tuberculosis Diseases 0.000 description 1
150000003751 zinc Chemical class 0.000 description 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Nutrition Science (AREA)
Biophysics (AREA)
Physiology (AREA)
Zoology (AREA)
Molecular Biology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Communicable Diseases (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Oncology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

ZA200510318A 2003-06-26 2005-12-20 Tablets containing enrofloxacin and flavouring agents and/or flavours ZA200510318B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DE10328666A DE10328666A1 (de)	2003-06-26	2003-06-26	Tabletten enthaltend Geschmacks-und/oder Aromastoffe

Publications (1)

Publication Number	Publication Date
ZA200510318B true ZA200510318B (en)	2007-04-25

Family

ID=33520986

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
ZA200510318A ZA200510318B (en)	2003-06-26	2005-12-20	Tablets containing enrofloxacin and flavouring agents and/or flavours

Country Status (30)

Country	Link
US (1)	US20090028936A1 (pt)
EP (1)	EP1641439B1 (pt)
JP (2)	JP5427341B2 (pt)
KR (1)	KR101119917B1 (pt)
CN (1)	CN100548280C (pt)
AR (2)	AR044704A1 (pt)
AU (1)	AU2004251003B2 (pt)
BR (1)	BRPI0411771B1 (pt)
CA (1)	CA2530639C (pt)
CO (1)	CO5650223A2 (pt)
CR (1)	CR8149A (pt)
DE (2)	DE10328666A1 (pt)
DK (1)	DK1641439T3 (pt)
ES (1)	ES2280973T3 (pt)
GT (1)	GT200400124A (pt)
IL (1)	IL172739A (pt)
MX (1)	MXPA05013875A (pt)
MY (1)	MY135825A (pt)
NO (1)	NO338438B1 (pt)
NZ (1)	NZ544365A (pt)
PE (1)	PE20050502A1 (pt)
PL (1)	PL1641439T3 (pt)
PT (1)	PT1641439E (pt)
RU (1)	RU2359699C2 (pt)
SI (1)	SI1641439T1 (pt)
TW (1)	TWI339124B (pt)
UA (1)	UA82529C2 (pt)
UY (1)	UY28380A1 (pt)
WO (1)	WO2005000275A1 (pt)
ZA (1)	ZA200510318B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CN100341510C (zh) *	2005-06-10	2007-10-10	冯莉萍	一种恩诺沙星微囊及制备方法
CN100360131C (zh) *	2006-01-24	2008-01-09	新昌国邦化学工业有限公司	一种掩味恩诺沙星的生产方法
WO2010034853A1 (es)	2008-09-23	2010-04-01	Laboratorio Jaer, S.A.	Utilización de exilitol o sus derivados para el enmascaramiento gustativo de quimioterapicos del grupo del ácido quinolon-o-naftiridoncarboxilico administrados en alimentos destinados a ganado porcino
RU2412704C1 (ru) *	2009-07-08	2011-02-27	Федеральное Государственное Образовательное Учреждение Высшего Профессионального Образования "Великолукская государственная сельскохозяйственная академия"	Способ лечения рожи свиней
MX347401B (es) *	2012-11-14	2017-04-18	Univ Mexico Nac Autonoma	Composicion de vehiculos y formas farmaceuticas de liberacion sostenida y aumento de biodisponibilidad de antibacterianos, anticoccidianos y otros farmacos en aves comericales y cerdos.
AU2013361760B2 (en)	2012-12-19	2018-07-05	Elanco Animal Health Gmbh	Tablets with improved acceptance and good storage stability
RU2554748C2 (ru) *	2013-07-09	2015-06-27	Общество с ограниченной ответственностью "БИОН"	Средство для лечения энтеритов у животных
MX356443B (es) *	2013-12-11	2018-05-21	Univ Mexico Nac Autonoma	Complejo recristalizado de clorhidrato de enrofloxacina dihidratado, y metodo para obtener el mismo.

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3719764A1 (de) *	1987-06-13	1988-12-22	Bayer Ag	Ionenaustauscherharze beladen mit chinoloncarbonsaeurederivaten, ihre herstellung und verwendung
EP0651640A1 (en) *	1992-07-21	1995-05-10	Knoll AG	Use of 7-fluoro-1-methyl-3-methylsulphinyl-4-quinolone in the treatment of angina pectoris
DE19633480A1 (de) *	1996-08-20	1998-02-26	Bayer Ag	Oral applizierbare Formulierungen von Chinolon- und Naphthyridoncarbonsäuren
US6004582A (en) *	1997-05-30	1999-12-21	Laboratorios Phoenix U.S.A, Inc.	Multi-layered osmotic device
US5980914A (en) *	1997-08-22	1999-11-09	P.N. Gerolymatos S.A.	Clioquinol for the treatment of Parkinson's disease
DE10031044A1 (de) *	2000-06-26	2002-01-03	Bayer Ag	Endoparasitizide Mittel zur freiwilligen oralen Aufnahme durch Tiere
EP1247456A3 (en) *	2001-02-28	2003-12-10	Pfizer Products Inc.	Palatable pharmaceutical compositions for companion animals
US20030190343A1 (en) *	2002-03-05	2003-10-09	Pfizer Inc.	Palatable pharmaceutical compositions for companion animals

2003
- 2003-06-26 DE DE10328666A patent/DE10328666A1/de not_active Withdrawn
2004
- 2004-06-14 BR BRPI0411771A patent/BRPI0411771B1/pt not_active IP Right Cessation
- 2004-06-14 CA CA2530639A patent/CA2530639C/en not_active Expired - Lifetime
- 2004-06-14 WO PCT/EP2004/006370 patent/WO2005000275A1/de not_active Ceased
- 2004-06-14 DE DE502004002690T patent/DE502004002690D1/de not_active Expired - Lifetime
- 2004-06-14 PT PT04739854T patent/PT1641439E/pt unknown
- 2004-06-14 DK DK04739854T patent/DK1641439T3/da active
- 2004-06-14 NZ NZ544365A patent/NZ544365A/en not_active IP Right Cessation
- 2004-06-14 US US10/559,995 patent/US20090028936A1/en not_active Abandoned
- 2004-06-14 AU AU2004251003A patent/AU2004251003B2/en not_active Expired
- 2004-06-14 CN CNB2004800180704A patent/CN100548280C/zh not_active Expired - Lifetime
- 2004-06-14 KR KR1020057024584A patent/KR101119917B1/ko not_active Expired - Lifetime
- 2004-06-14 PL PL04739854T patent/PL1641439T3/pl unknown
- 2004-06-14 UA UAA200600683A patent/UA82529C2/uk unknown
- 2004-06-14 ES ES04739854T patent/ES2280973T3/es not_active Expired - Lifetime
- 2004-06-14 SI SI200430201T patent/SI1641439T1/sl unknown
- 2004-06-14 MX MXPA05013875A patent/MXPA05013875A/es active IP Right Grant
- 2004-06-14 RU RU2006102033/15A patent/RU2359699C2/ru active
- 2004-06-14 JP JP2006515918A patent/JP5427341B2/ja not_active Expired - Lifetime
- 2004-06-14 EP EP04739854A patent/EP1641439B1/de not_active Expired - Lifetime
- 2004-06-15 AR ARP040102069A patent/AR044704A1/es not_active Application Discontinuation
- 2004-06-22 GT GT200400124A patent/GT200400124A/es unknown
- 2004-06-23 UY UY28380A patent/UY28380A1/es not_active IP Right Cessation
- 2004-06-24 MY MYPI20042477A patent/MY135825A/en unknown
- 2004-06-25 TW TW093118390A patent/TWI339124B/zh not_active IP Right Cessation
- 2004-06-25 PE PE2004000619A patent/PE20050502A1/es active IP Right Grant
2005
- 2005-12-14 CR CR8149A patent/CR8149A/es not_active Application Discontinuation
- 2005-12-20 ZA ZA200510318A patent/ZA200510318B/en unknown
- 2005-12-21 IL IL172739A patent/IL172739A/en active IP Right Grant
- 2005-12-26 CO CO05129984A patent/CO5650223A2/es not_active Application Discontinuation
2006
- 2006-01-05 NO NO20060065A patent/NO338438B1/no unknown
2011
- 2011-10-06 JP JP2011221646A patent/JP2012046533A/ja active Pending
2016
- 2016-01-29 AR ARP160100259A patent/AR103567A2/es not_active Application Discontinuation

Also Published As

Publication number	Publication date
CA2530639A1 (en)	2005-01-06
GT200400124A (es)	2005-03-03
PL1641439T3 (pl)	2007-08-31
PT1641439E (pt)	2007-04-30
NZ544365A (en)	2009-10-30
BRPI0411771B1 (pt)	2015-11-24
CN100548280C (zh)	2009-10-14
RU2006102033A (ru)	2006-06-10
SI1641439T1 (sl)	2007-06-30
TWI339124B (en)	2011-03-21
UY28380A1 (es)	2005-01-31
AR044704A1 (es)	2005-09-21
TW200503759A (en)	2005-02-01
KR20060063802A (ko)	2006-06-12
NO338438B1 (no)	2016-08-15
AU2004251003B2 (en)	2010-09-16
MXPA05013875A (es)	2006-07-06
JP2012046533A (ja)	2012-03-08
DE502004002690D1 (de)	2007-03-08
DK1641439T3 (da)	2007-04-10
CA2530639C (en)	2012-01-03
CO5650223A2 (es)	2006-06-30
CN1812769A (zh)	2006-08-02
AR103567A2 (es)	2017-05-17
JP2007506658A (ja)	2007-03-22
WO2005000275A1 (de)	2005-01-06
IL172739A0 (en)	2006-04-10
DE10328666A1 (de)	2005-01-13
BRPI0411771A (pt)	2006-08-29
AU2004251003A1 (en)	2005-01-06
MY135825A (en)	2008-07-31
PE20050502A1 (es)	2005-08-18
KR101119917B1 (ko)	2012-02-29
ES2280973T3 (es)	2007-09-16
JP5427341B2 (ja)	2014-02-26
CR8149A (es)	2007-09-12
UA82529C2 (uk)	2008-04-25
US20090028936A1 (en)	2009-01-29
RU2359699C2 (ru)	2009-06-27
IL172739A (en)	2010-12-30
HK1095515A1 (zh)	2007-05-11
EP1641439A1 (de)	2006-04-05
EP1641439B1 (de)	2007-01-17
NO20060065L (no)	2006-01-05

Publication	Publication Date	Title
EP2063869B1 (en)	2014-03-05	Soft chewable veterinary antibiotic formulations
JP2012046533A (ja)	2012-03-08	エンロフロキサシン並びに風味剤および／または芳香化物質を含む錠剤
US20110065719A1 (en)	2011-03-17	Pharmaceutical formulations containing flavouring substances with improved pharmaceutical
US5808076A (en)	1998-09-15	Orally administrable formulations of quinolone- or naphthyridonecarboxylic acids
JPS6222716A (ja)	1987-01-30	獣医学の分野に使用する殺バクテリア調製物
HK1095515B (en)	2010-07-23	Tablets containing enrofloxacin and flavouring agents and/or flavours
HK1131552B (en)	2014-07-11	Soft chewable veterinary antibiotic formulations
MXPA06004857A (en)	2007-04-20	Pharmaceutical formulations containing flavouring substances with improved pharmaceutical properties